DK1343766T3 - Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner - Google Patents

Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner

Info

Publication number
DK1343766T3
DK1343766T3 DK01990192T DK01990192T DK1343766T3 DK 1343766 T3 DK1343766 T3 DK 1343766T3 DK 01990192 T DK01990192 T DK 01990192T DK 01990192 T DK01990192 T DK 01990192T DK 1343766 T3 DK1343766 T3 DK 1343766T3
Authority
DK
Denmark
Prior art keywords
naphthyridines
quinolones
cyclization
preparation
process step
Prior art date
Application number
DK01990192T
Other languages
English (en)
Inventor
Sreenivasa Reddy Mundla
Jared Lynn Randall
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK1343766T3 publication Critical patent/DK1343766T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK01990192T 2000-12-14 2001-12-07 Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner DK1343766T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25563300P 2000-12-14 2000-12-14
PCT/US2001/048536 WO2002048113A1 (en) 2000-12-14 2001-12-07 Cyclization process step in the making of quinolones and naphthyridines

Publications (1)

Publication Number Publication Date
DK1343766T3 true DK1343766T3 (da) 2005-10-31

Family

ID=22969207

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01990192T DK1343766T3 (da) 2000-12-14 2001-12-07 Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner

Country Status (19)

Country Link
EP (1) EP1343766B1 (da)
JP (2) JP4417007B2 (da)
KR (1) KR100603163B1 (da)
CN (1) CN1232508C (da)
AT (1) ATE300522T1 (da)
AU (2) AU2905702A (da)
BR (1) BR0116229A (da)
CA (1) CA2427831C (da)
CZ (1) CZ20031379A3 (da)
DE (1) DE60112325T2 (da)
DK (1) DK1343766T3 (da)
ES (1) ES2247190T3 (da)
HU (1) HUP0303991A3 (da)
IL (2) IL155677A0 (da)
MX (1) MXPA03005338A (da)
NO (1) NO325236B1 (da)
NZ (1) NZ525569A (da)
PL (1) PL207394B1 (da)
WO (1) WO2002048113A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100735587B1 (ko) * 2002-08-05 2007-07-04 더 프록터 앤드 갬블 캄파니 퀴놀론계 항생제 중간체의 제조 방법
US6803469B2 (en) * 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
EP4059923A1 (en) * 2002-11-20 2022-09-21 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
US7402674B2 (en) 2004-01-31 2008-07-22 Sanofi-Aventis Deutschland Gmbh, 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
CN101437801B (zh) 2006-03-06 2013-02-06 日本烟草产业株式会社 制备4-氧代喹啉化合物的方法
PL1992607T3 (pl) 2006-03-06 2015-05-29 Japan Tobacco Inc Sposób wytwarzania związku 4-oksochinolinowego
MX2009002689A (es) * 2006-09-12 2009-03-26 Gilead Sciences Inc Proceso e intermediarios para preparar inhibidores de integrasa.
US8658183B2 (en) 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
AR068403A1 (es) 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
NZ588898A (en) 2008-07-01 2012-09-28 Taigen Biotechnology Co Ltd Use of nemonoxacin for treating antibiotic-resistant staphylococcus aureus infection
US8877931B2 (en) 2012-08-03 2014-11-04 Gilead Sciences, Inc. Process and intermediates for preparing integrase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ290722A (en) * 1994-08-02 1999-03-29 Procter & Gamble A process for making derivatives of quinolonyl lactam (qla's); intermediates
DE69515882T2 (de) * 1994-08-02 2000-11-02 Procter & Gamble Verfahren zur herstellung von antimikrobiellen verbindungen

Also Published As

Publication number Publication date
PL363355A1 (en) 2004-11-15
NO20032667L (no) 2003-08-14
HUP0303991A3 (en) 2012-09-28
IL155677A (en) 2009-02-11
PL207394B1 (pl) 2010-12-31
CA2427831A1 (en) 2002-06-20
WO2002048113A1 (en) 2002-06-20
DE60112325T2 (de) 2006-05-24
KR20030063420A (ko) 2003-07-28
JP2010001315A (ja) 2010-01-07
HUP0303991A2 (hu) 2004-04-28
DE60112325D1 (de) 2005-09-01
EP1343766B1 (en) 2005-07-27
CZ20031379A3 (cs) 2003-11-12
NO20032667D0 (no) 2003-06-12
AU2002229057B2 (en) 2005-04-21
JP4417007B2 (ja) 2010-02-17
MXPA03005338A (es) 2003-10-06
NZ525569A (en) 2004-09-24
AU2905702A (en) 2002-06-24
CN1481365A (zh) 2004-03-10
EP1343766A1 (en) 2003-09-17
CN1232508C (zh) 2005-12-21
CA2427831C (en) 2009-08-18
ATE300522T1 (de) 2005-08-15
NO325236B1 (no) 2008-03-03
JP2004515542A (ja) 2004-05-27
IL155677A0 (en) 2003-11-23
KR100603163B1 (ko) 2006-07-24
BR0116229A (pt) 2003-11-04
ES2247190T3 (es) 2006-03-01

Similar Documents

Publication Publication Date Title
PT1070056E (pt) Inibidores de pde iii/iv a base de ftalazinona
NO20024869L (no) Oksygenatomdanningsprosess
DK1343766T3 (da) Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
ATE411287T1 (de) Neue metallproteinaseinhibitoren
BR0211826A (pt) Imidazopiridinas tricìclicas
DK1373255T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
GB0019124D0 (en) Novel process
MXPA04000771A (es) Metodo para nitracion de compuestos fenolicos.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
DK1280752T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-chlorphenoler
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
DK1250335T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner
DK1085019T3 (da) Omoprazolsyntese
SE0101323D0 (sv) New process
DK1320527T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler
DK1694684T3 (da) Fremgangsmåde til fremstilling af camptothecinderivater
SE0000382D0 (sv) New process
WO2003044877A3 (en) Light emitting device and compounds for use therein
DE50203367D1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
NO20033840D0 (no) Fremgangsmåte for fremstilling av mirtazapinmellomprodukter
DK1315702T3 (da) Fremgangsmåde til fremstilling af halogen-4-phenoxyquinoliner
DK1171542T3 (da) Fremgangsmåde til fremstilling af oxygenfjernende forseglingsmiddelsammensætninger